Stock Analysis

3 SEHK Stocks Estimated To Be Trading Below Intrinsic Value By Up To 40.9%

SEHK:2522
Source: Shutterstock

In recent weeks, the Hong Kong market has seen fluctuations, with the Hang Seng Index experiencing a decline of 2.11% as concerns over deflationary pressures in China persist. Amid these conditions, investors are increasingly on the lookout for stocks that may be undervalued relative to their intrinsic worth, presenting potential opportunities for those who can identify companies trading below their estimated value by significant margins.

Top 10 Undervalued Stocks Based On Cash Flows In Hong Kong

NameCurrent PriceFair Value (Est)Discount (Est)
BYD Electronic (International) (SEHK:285)HK$34.50HK$63.7845.9%
Giant Biogene Holding (SEHK:2367)HK$50.70HK$98.2348.4%
Kuaishou Technology (SEHK:1024)HK$46.25HK$88.5047.7%
MicroPort NeuroScientific (SEHK:2172)HK$9.72HK$18.8348.4%
Yadea Group Holdings (SEHK:1585)HK$12.32HK$23.2146.9%
Shanghai INT Medical Instruments (SEHK:1501)HK$28.50HK$55.6948.8%
Hangzhou SF Intra-city Industrial (SEHK:9699)HK$10.24HK$19.4847.4%
Semiconductor Manufacturing International (SEHK:981)HK$29.60HK$54.8546%
CSC Financial (SEHK:6066)HK$9.36HK$17.1945.5%
Akeso (SEHK:9926)HK$67.00HK$127.7747.6%

Click here to see the full list of 39 stocks from our Undervalued SEHK Stocks Based On Cash Flows screener.

Let's review some notable picks from our screened stocks.

Hua Hong Semiconductor (SEHK:1347)

Overview: Hua Hong Semiconductor Limited is an investment holding company that manufactures and sells semiconductor products, with a market capitalization of HK$50.34 billion.

Operations: Revenue segments for Hua Hong Semiconductor Limited include manufacturing and selling semiconductor products.

Estimated Discount To Fair Value: 40.9%

Hua Hong Semiconductor is trading at HK$23.3, significantly below its estimated fair value of HK$39.44, suggesting it may be undervalued based on cash flows. Despite a drop in second-quarter sales to US$478.52 million from US$631.38 million last year and lower profit margins, earnings are expected to grow significantly by 33.33% annually over the next three years, outpacing the Hong Kong market's growth rate of 12.1%.

SEHK:1347 Discounted Cash Flow as at Oct 2024
SEHK:1347 Discounted Cash Flow as at Oct 2024

AviChina Industry & Technology (SEHK:2357)

Overview: AviChina Industry & Technology Company Limited develops, manufactures, and sells civil aviation and defense products in Hong Kong and internationally, with a market cap of HK$31.81 billion.

Operations: The company's revenue segments include Aviation Entire Aircraft at CN¥20.16 billion, Aviation Engineering Services at CN¥11.05 billion, and Aviation Ancillary System and Related Business at CN¥53.01 billion.

Estimated Discount To Fair Value: 10.5%

AviChina Industry & Technology is trading at HK$3.99, slightly below its estimated fair value of HK$4.46, indicating potential undervaluation based on cash flows. Despite a decrease in half-year revenue to CNY 33.62 billion from CNY 40.87 billion last year, earnings are projected to grow significantly by over 20% annually for the next three years, surpassing the Hong Kong market's growth rate of 12.1%.

SEHK:2357 Discounted Cash Flow as at Oct 2024
SEHK:2357 Discounted Cash Flow as at Oct 2024

Jiangxi Rimag Group (SEHK:2522)

Overview: Jiangxi Rimag Group Co., Ltd. operates medical imaging centers in China with a market cap of HK$11.69 billion.

Operations: The company generates revenue of CN¥812.85 million from its Medical Labs & Research segment.

Estimated Discount To Fair Value: 33%

Jiangxi Rimag Group, trading at HK$32.8, is significantly undervalued compared to its fair value estimate of HK$48.94. Despite a drop in half-year sales from CNY 529.78 million to CNY 413.71 million and net income from CNY 42.98 million to CNY 3.84 million, earnings are forecasted to grow by over 70% annually for the next three years, outpacing the Hong Kong market's growth rate of 12.1%.

SEHK:2522 Discounted Cash Flow as at Oct 2024
SEHK:2522 Discounted Cash Flow as at Oct 2024

Where To Now?

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com